title: Gilenya safety update:  cardiac and macula.
authors.forename: Alison
authors.initials: A
authors.lastname: Huggins
authors.forename: Robert C
authors.initials: RC
authors.lastname: Sergott
mesh_terms: D001919:Bradycardia / Q000139:chemically induced*; D016903:Drug Monitoring; D000068876:Fingolimod Hydrochloride; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008269:Macular Edema / Q000139:chemically induced*; D009103:Multiple Sclerosis / Q000188:drug therapy; D011409:Propylene Glycols / Q000009:adverse effects* / Q000627:therapeutic use; D013110:Sphingosine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine